Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Denali Therapeutics (4DN.F) Q2 2025 Earnings
4DN.F
6
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.77
-0.69
-0.62
-0.55
Details
Expected EPS
-0.61399340415
Actual EPS
-0.687609
Surprise EPS
-0.07
Surprise Percent
+11.99%
Description
Denali Therapeutics (4DN.F) has reported earnings of -0.687609 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login